Home Tags Sapience Therapeutics Inc.

Tag: Sapience Therapeutics Inc.

Sapience Therapeutics announces collaboration with University of Bath

Under the terms of the agreement, Sapience will have exclusive rights to the development and commercialization of any novel compounds that arise from the research.

New York Medical College names Deborah Novick director of biotech incubator

Novick will be responsible for overseeing the daily operations for the life sciences incubator on the college's Valhalla campus.

Sapience Therapeutics ST-36 receives orphan drug designation from FDA

ST-36 selectively targets a protein that promotes the growth of many types of tumors including glioblastoma, the most deadly form of brain cancer.

New York Medical College incubator adds therapeutics startup

New York Medical College's BioInc@NYMC biotech incubator will add a seventh tenant to its Valhalla campus.